| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | Sep 25, 2023 | MEI Pharma, Inc. | 10% Owner | Buy | 90.0 | +32,040 | 7.47% | ✗ | $219.6K |
| Sep 20, 2023 | Sep 22, 2023 | MEI Pharma, Inc. | 10% Owner | Buy | 97.5 | +102,400 | 31.37% | ✗ | $625.5K |
| May 23, 2022 | May 25, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 87.5 | +85,262 | 3.42% | ✗ | $197.4K |
| May 18, 2022 | May 20, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 68.8 | +13,073 | 0.53% | ✗ | $30.1K |
| May 12, 2022 | May 16, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 87.5 | +84,836 | 3.54% | ✗ | $194.1K |
| May 10, 2022 | May 11, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 82.5 | +45,575 | 1.94% | ✗ | $104.1K |
| May 5, 2022 | May 9, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 92.5 | +124,122 | 5.57% | ✗ | $282.6K |
| Apr 28, 2022 | May 2, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 82.5 | +33,614 | 1.53% | ✗ | $77.7K |
| Apr 25, 2022 | Apr 27, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 68.8 | +13,751 | 0.63% | ✗ | $31.5K |
| Apr 18, 2022 | Apr 20, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 61.3 | +9,119 | 0.42% | ✗ | $21.1K |
| Apr 14, 2022 | Apr 14, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 68.8 | +17,410 | 0.81% | ✗ | $40.5K |
| Apr 8, 2022 | Apr 12, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 90.0 | +104,713 | 5.11% | ✗ | $242.7K |
| Apr 5, 2022 | Apr 7, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 90.0 | +103,984 | 5.35% | ✗ | $239.8K |
| Apr 4, 2022 | Apr 7, 2022 | Oruka Therapeutics, Inc. | Other | Buy | 92.5 | +122,342 | 6.71% | ✗ | $276.3K |